Pharma lobbying group ousts 22 drugmakers amid U.S. pricing debate
The pharmaceutical industry’s powerful Washington, D.C., trade association, which includes Eli Lilly and Co., fell in size by almost two dozen companies after revising membership rules amid the debate over U.S. drug prices.